Concurrent Activation of Both Survival-Promoting and Death-Inducing Signaling by Chloroquine in Glioblastoma Stem Cells: Implications for Potential Risks and Benefits of Using Chloroquine as Radiosensitizer
Authors:
- Andreas MüllerAMAndreas Müller
- Patrick WeyerhäuserPWPatrick Weyerhäuser
- Nancy BerteNBNancy Berte
- Fitriasari JoninFJFitriasari Jonin
- Bogdan LyubarskyyBLBogdan Lyubarskyy
- Bettina SprangBSBettina Sprang
- Sven Rainer KantelhardtSKSven Rainer Kantelhardt
- Gabriela SalinasGSGabriela Salinas
- Lennart OpitzLOLennart Opitz
- Walter Schulz-SchaefferWSWalter Schulz-Schaeffer
- Alf GieseAGAlf Giese
- Ella L. KimEKElla L. Kim
Open Access
Abstract
Lysosomotropic agent chloroquine was shown to sensitize non-stem glioblastoma cells to radiation in vitro with p53-dependent apoptosis implicated as one of the underlying mechanisms. The in vivo outcomes of chloroquine or its effects on glioblastoma stem cells have not been previously addressed. This study undertakes a combinatorial approach encompassing in vitro, in vivo and in silico investigations to address the relationship between chloroquine-mediated radiosensitization and p53 status in glioblastoma stem cells. Our findings reveal that chloroquine elicits antagonistic impacts on signaling pathways involved in the regulation of cell fate via both transcription-dependent and transcription-independent mechanisms. Evidence is provided that transcriptional impacts of chloroquine are primarily determined by p53 with chloroquine-mediated activation of pro-survival mevalonate and p21-DREAM pathways being the dominant response in the background of wild type p53. Non-transcriptional effects of chloroquine are conserved and converge on key cell fate regulators ATM, HIPK2 and AKT in glioblastoma stem cells irrespective of their p53 status. Our findings indicate that pro-survival responses elicited by chloroquine predominate in the context of wild type p53 and are diminished in cells with transcriptionally impaired p53. We conclude that p53 is an important determinant of the balance between pro-survival and pro-death impacts of chloroquine and propose that p53 functional status should be taken into consideration when evaluating the efficacy of glioblastoma radiosensitization by chloroquine.Keywords
Funding Information
- Monika-Kutzner Foundation (16082018, 09092021)
- FAZIT Foundation (16082018, 09092021)
This publication has 96 references indexed in Scilit:
- Human Glioma–Initiating Cells Show a Distinct Immature Phenotype Resembling but Not Identical to NG2 GliaJournal of Neuropathology & Experimental Neurology, 2013
- Chloroquine activates the p53 pathway and induces apoptosis in human glioma cellsNeuro-Oncology, 2010
- ATM activates p53 by regulating MDM2 oligomerization and E3 processivityThe EMBO Journal, 2009
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agentsJournal of Cell Biology, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Inhibition of Phosphatidylinositol-3-OH Kinase/Akt Signaling Impairs DNA Repair in Glioblastoma Cells following Ionizing RadiationJournal of Biological Chemistry, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociationNature, 2003